Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1632 1656 1682 1737 1758 1796 1797 1798 1799
This examiner grants 33% of resolved cases
Examiner BENJAMIN JOSEPH KASS is assigned to Tech Center 1700 and Art Unit 1632. The examiner has 43 resolved cases, which provides a solid statistical basis for understanding prosecution trends. This 43 case volume is sufficient to identify consistent patterns in allowance rates and timelines.
The allowance rate is 32.6 percent. While this 32.6 percent rate indicates a rigorous examination environment, the interview lift is 58.9 percent. This 58.9 percent lift is very high, suggesting that interviews are a highly effective tool for improving the chances of a grant compared to the 32.6 percent baseline. Practitioners in Art Unit 1632 should prioritize interviews to overcome the challenges reflected in the overall allowance rate.
The median days to allowance is 1395. This 1395 day timeframe is the median duration for successful applications to reach issuance. The 32.6 percent allowance rate and the 1395 day median highlight the importance of a strategic approach in Tech Center 1700. The 58.9 percent interview lift offers a clear and effective path for applicants to improve their results.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17780194 | MICROFLUIDIC CHIP AND MICROFLUIDIC DEVICE | Final Rejection | BOE TECHNOLOGY GROUP CO., LTD. |
| 17524840 | Device, System and Method for Fluid Delivery for Sequencing | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 18070887 | FLOW CELLS AND METHODS OF USE THEREOF | Non-Final OA | 10x Genomics, Inc. |
| 17756254 | APPARATUS, SYSTEMS, AND METHODS OF TRANSFERRING LIQUIDS CONTAINING AGGREGATES | Final Rejection | Siemens Healthcare Diagnostics Inc. |
| 18564531 | FLUORESCENCE DETECTION VIA OUTCOUPLERS | Final Rejection | Hewlett-Packard Development Company, L.P. |
| 18016860 | IDENTIFYING TARGET NUCLEIC ACIDS USING IMMOBILIZED NUCLEASE | Non-Final OA | Hewlett-Packard Development Company, L.P. |
| 18370181 | COMBINABLE NUCLEIC ACID PRE-PROCESSING APPARATUS | Non-Final OA | Delta Electronics, Inc. |
| 17509229 | DEVICES AND SYSTEMS FOR DELIVERY OF MATERIALS TO CELLS | Non-Final OA | Massachusetts Institute of Technology |
| 17996602 | AUTOMATIC ANALYZER | Final Rejection | HITACHI HIGH-TECH CORPORATION |
| 17781965 | Automatic Analysis Device | Final Rejection | Hitachi High-Tech Corporation |
| 17768288 | AUTOMATIC ANALYZER | Final Rejection | Hitachi High-Tech Corporation |
| 18536537 | BIO-ENHANCED REMEDIATION AND OIL RECOVERY MODEL SYSTEM AND METHODS | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 17693773 | MICROFLUIDIC CARTRIDGES FOR ENHANCED AMPLIFICATION OF POLYNUCLEOTIDE-CONTAINING SAMPLES | Final Rejection | BECTON, DICKINSON AND COMPANY |
| 17942296 | MICROCHANNEL DEVICE | Final Rejection | Shimadzu Corporation |
| 17576968 | Liquid Biological Sample Test Cartridge | Non-Final OA | Purdue Research Foundation |
| 17618689 | A CONTROL UNIT AND A CASSETTE INSERTABLE IN A MILK ANALYSIS APPARATUS | Non-Final OA | DELAVAL HOLDING AB |
| 17590865 | DEVICE FOR MOVING PROBES | Non-Final OA | STRATEC SE |
| 18386759 | CARTRIDGE FOR DETECTING TARGET ANALYTE | Final Rejection | SEEGENE, INC. |
| 17719014 | Vaporizer Device Microfluidic Systems and Apparatuses | Non-Final OA | JUUL Labs, Inc. |
| 18542447 | FLOW CELLS | Non-Final OA | ILLUMINA, INC. |
| 17790077 | FLOW CELL ASSEMBLIES AND RELATED REAGENT SELECTOR VALVES | Final Rejection | ILLUMINA, INC. |
| 18373019 | LIQUID TRANSFER DEVICE AND METHOD, BIOCHEMICAL SUBSTANCE REACTION DEVICE, AND BIOCHEMICAL SUBSTANCE ANALYSIS DEVICE AND METHOD | Non-Final OA | MGI Tech Co., Ltd. |
| 18017891 | ELECTRODE INTEGRATED MICROSIEVE ASSEMBLY | Final Rejection | TECHNISCHE UNIVERSITEIT EINDHOVEN |
| 18707296 | SYSTEMS, METHODS, AND DEVICES FOR ACHIEVING SUITABLE SAMPLE THICKNESS FOR SINGLE PARTICLE CRYO-ELECTRON MICROSCOPY | Non-Final OA | MiTeGen, LLC |
| 17705311 | System and Method for Dual Bio-Sensor Fabrication and Use | Final Rejection | VOC HEALTH, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy